Overview
Rajiv Panikkar, MD, is the chair of the Geisinger Cancer Institute.|Dr. Panikkar was raised in Bloomsburg, Pa. He received his Doctor of Medicine degree from the University of Pittsburgh. He completed his residency in internal medicine at Virginia Commonwealth University Hospital, where he served as chief medical resident. His hematology/oncology fellowship was at Temple University Hospital/Fox Chase Cancer Center. He is board certified in hematology and oncology, and he practices as a medical oncologist.|Dr. Panikkar came to Geisinger in 2008 as a medical oncologist at Geisinger Medical Center. As chair of the Geisinger Cancer Institute, he currently leads 11 hematology/oncology, 6 radiation oncology and 4 palliative medicine sites across Pennsylvania. He is the principal investigator for Geisinger’s National Cancer Institute Community Research Program, a collaborative network designed to conduct oncology clinical trials and generate new knowledge through cancer care delivery research.|“The Geisinger Cancer Institute has an amazing opportunity to provide compassionate, patient-focused care close to home. We are expanding clinical trial opportunities and providing new medications and new technology to our communities. Our commitment to a team approach allows us to bring highly trained physicians together who are focused on the patient. Working at Geisinger is special — it has given me the opportunity to care for families I grew up with. I am excited about the growth of comprehensive services for the patients in our region."".
Dr. Panikkar is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Arterial Embolism, and Familial Colorectal Cancer.
His clinical research consists of co-authoring 10 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of Small Cell Lung Cancer (SCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 North Academy Avenue, Danville, PA 17822
1000 East Mountain Boulevard, Wilkes Barre, PA 18711
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
The Milton S Hershey Medical Center Physicians Group
Takefumi Komiya is an Oncologist and a Hematologist in Hershey, Pennsylvania. Dr. Komiya is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Chandra Belani is a Hematologist Oncology specialist and an Oncologist in Hershey, Pennsylvania. Dr. Belani is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.
Meide Lu is a Hematologist Oncology specialist and a Hematologist in West Reading, Pennsylvania. Dr. Lu is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and ALK-Positive Non-Small Cell Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Arterial EmbolismDr. Panikkar isDistinguished. Learn about Arterial Embolism.
- Lung CancerDr. Panikkar isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Panikkar isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Panikkar isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Panikkar isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Panikkar isAdvanced. Learn about Familial Pancreatic Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Large-Cell Lung CarcinomaDr. Panikkar isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Panikkar isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adenoid Cystic CarcinomaDr. Panikkar isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Panikkar isExperienced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Panikkar isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Panikkar isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Panikkar isExperienced. Learn about Alveolar Soft Part Sarcoma.